Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients

Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients

Abstract Background Current treatment of acute leukemia is based on anthracycline chemotherapy. Anthracyclines, despite improving patient survival, have serious cardiotoxicity and therefore cardiac monitoring should be a priority. The purpose of this study is to explore the possible early predictors...

Full description

Bibliographic Details
Main Authors: Xi Zhou, Yue Weng, Tiantian Jiang, Wenxin Ou, Nan Zhang, Qian Dong, Xiaoqiong Tang
Format: Article
Language:English
Published: BMC 2023-10-01
Series:BMC Cancer
Subjects:
Acute leukemia
Anthracycline
Subclinical cardiotoxicity
Influencing factors
Online Access:https://doi.org/10.1186/s12885-023-11060-5

Internet

https://doi.org/10.1186/s12885-023-11060-5

Similar Items